TY - JOUR
T1 - Erratum
T2 - Targeting CD137 enhances the efficacy of cetuximab(J Clin Invest. (2019)129:6 (2595-2595) DOI: 10.1172/JCI129689)
AU - Kohrt, Holbrook E.
AU - Colevas, A. Dimitrios
AU - Houot, Roch
AU - Weiskopf, Kipp
AU - Goldstein, Matthew J.
AU - Lund, Peder
AU - Mueller, Antonia
AU - Sagiv-Barfi, Idit
AU - Marabelle, Aurelien
AU - Lira, Ruth
AU - Troutner, Emily
AU - Richards, Lori
AU - Rajapaska, Amanda
AU - Hebb, Jonathan
AU - Chester, Cariad
AU - Waller, Erin
AU - Ostashko, Anton
AU - Weng, Wen Kai
AU - Chen, Lieping
AU - Czerwinski, Debra
AU - Fu, Yang Xin
AU - Sunwoo, John
AU - Levy, Ronald
N1 - Publisher Copyright:
© 2019 American Society for Clinical Investigation. All rights reserved.
PY - 2019/6/3
Y1 - 2019/6/3
N2 - Stanford University School of Medicine recently notified the JCI of concerns regarding Figure 4, B, C, and E, Figure 5, B, D, and F, and Figure 6B and indicated that the original source data for these figures could not be located. In accordance with the institutional recommendation, the JCI is retracting this article.
AB - Stanford University School of Medicine recently notified the JCI of concerns regarding Figure 4, B, C, and E, Figure 5, B, D, and F, and Figure 6B and indicated that the original source data for these figures could not be located. In accordance with the institutional recommendation, the JCI is retracting this article.
UR - http://www.scopus.com/inward/record.url?scp=85066607597&partnerID=8YFLogxK
U2 - 10.1172/JCI73014
DO - 10.1172/JCI73014
M3 - Comment/debate
C2 - 24837434
AN - SCOPUS:85066607597
SN - 0021-9738
VL - 129
SP - 2595
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 6
ER -